Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths.
These tablets are the generic equivalent of Oxtellar XR® ER Tablets by Supernus Pharmaceuticals and are indicated for the treatment of partial-onset seizures in patients aged 6 years and above. Lupin's version of the drug will be manufactured at its Nagpur facility in India.
According to IQVIA MAT April 2025 data, Oxcarbazepine ER Tablets (RLD Oxtellar XR®) recorded estimated annual sales of USD 206 million in the United States, underscoring the potential market opportunity for Lupin.
Headquartered in Mumbai, Lupin is a leading global pharmaceutical company with a strong footprint in the U.S. and India. The company focuses on a broad range of therapy areas including central nervous system disorders, respiratory, cardiovascular, anti-infective, and women's health. It operates 15 manufacturing sites and 7 research centers globally, supported by over 23,000 employees.
Lupin continues to expand its U.S. portfolio of complex generics and remains committed to delivering high-quality, affordable medicines that improve health outcomes for patients around the world.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Securities Fraud Investigation Into Bausch + Lomb Corporation (BLCO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Bausch + Lomb Corporation ('BLCO' or the 'Company') (NYSE: BLCO) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAUSCH + LOMB CORPORATION (BLCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 27, 2025, BLCO disclosed that it had '[begun] to see an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with enVista® intraocular lenses (IOLs)' and was voluntarily recalling all of its enVista Envy and enVista Aspire IOLs, as well as enVista monofocal lenses. On this news, BLCO's stock price fell $1.54, or 9.8%, over two consecutive trading days to close at $14.13 per share on March 28, 2025, thereby injuring investors. Then, on April 30, 2025, BLCO released its first quarter 2025 financial results, disclosing that 'as enVista ramps back up, for the full year 2025, [it] estimate[s] one-time recall headwinds of approximately $55 million to revenue and $65 million to adjusted EBITDA.' On this news, BLCO's stock price fell $2.16, or 15.7%, to close at $11.56 per share on April 30, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. Whistleblower Notice Persons with non-public information regarding BLCO should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@ About Glancy Prongay & Murray LLP Glancy Prongay & Murray LLP ('GPM') is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. GPM has been consistently ranked in the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM's nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPM's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
USA Today
an hour ago
- USA Today
Marquis Who's Who Listee Brian Fricker Featured on Innovator's Journey to Discuss Staffing Partners Inc.
Brian Fricker, president of Staffing Partners Inc., was featured on Innovator's Journey to discuss the unique staffing services his company offers. Under Mr. Fricker's leadership, Staffing Partners Inc. has become one of the top staffing agencies in the state of Wisconsin. Unlike other staffing companies, the agency offers transportation and PPE equipment for all employees. Through the BakPak division, the company is able to provide a warehouse space with a forklift and loading dock where clients can have assembly, packaging and fulfillment services completed. Looking to the future, Mr. Fricker hopes to expand Staffing Partners Inc. out of Wisconsin. For more information, visit About Marquis Who's Who®: Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at For more information about TV Interviews, please contact us at tvinterviews@
CNET
an hour ago
- CNET
A New Welcome Offer for The Platinum Card® from American Express Gives Me Pause. Here's Why
CNET/Getty Images Would you apply for a credit card that costs hundreds of dollars if the issuer wouldn't tell you what the welcome offer was? American Express recently changed the language for the terms on The Platinum Card® from American Express without specifying the exact number of points you'd be eligible to earn with its welcome offer. A credit card's welcome bonus -- a lump sum of rewards you can earn typically for reaching a certain spending threshold in a specified number of months -- is one of the main reasons why people apply for luxury travel credit cards. The annual fee on an expensive credit card can usually be offset by the welcome offer you can earn. So, a card with a $600 annual fee and a welcome bonus of 100,000 points (depending on how much those points are worth), you know that fee is covered for at least a year. American Express did not respond to questions in time for publication. So what changed with The Platinum Card? I'll explain. What changed with The Platinum Card's welcome offer? Here's how Amex changed its language: Old offer: 80,000 points for spending $8,000 in the first six months. 80,000 points for spending $8,000 in the first six months. New offer: You may be eligible for as high as 175,000 Membership Rewards® Points after you spend $8,000 in eligible purchases on your new Card in your first six months of Card Membership. Welcome offers vary and you may not be eligible for an offer. Find out your exact welcome offer when you apply. It's a mouthful, I know. As someone who's covered credit cards for nearly a decade, it's a good reminder to read all of the terms carefully. Here's what you should pay attention to. Why you should read the offer carefully A few things to call out with this new language. As high as. Yes, 175,000 is a big number. However, they don't disclose the range. That leaves me to wonder what's the least amount you might earn on a card with a $695 annual fee. (See rates and fees; terms apply.) Welcome offers vary and you may not be eligible for this offer. This could mean that you may not qualify for the highest payout or, in the worst case, that you may not qualify at all. Either way, the wording is ambiguous. Find out your exact welcome offer when you apply. You're no longer told how much you're eligible to earn before applying. Let's say you're approved, expecting a 175,000 bonus, but instead only qualify for 60,000. At that point, you'd have to decide if the card is valuable enough to you to accept. On the plus side, Amex says your credit score is only impacted if you accept the card -- not when you apply. Should you apply for the Amex Platinum? If you had plans to apply for the card, it might be worth holding off until the company clarifies the bonus -- perhaps that will come with its planned update to the card later this year. Otherwise, the welcome offer you receive may not match your expectations. It could be that the credit card issuer is putting this out now, ahead of the planned update in preparation for a rewards revamp. Amex might offer tiers of Platinum cards, each with a different welcome offer and rewards, but that's just speculation. Either way, the change in language and the lack of disclosure about the welcome offer give me pause. Similar to how the new Coinbase One Card won't disclose how many assets you need to qualify for the highest rewards rate, the new language strikes me as purposefully ambiguous to get people to apply, only to find out the benefits are much less than what they expected.
